ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC
By
ESMO 2022 Conference Coverage
FEATURING
Marcin Dzienis
By
ESMO 2022 Conference Coverage
FEATURING
Marcin Dzienis
67 views
September 30, 2022
Comments 0
Login to view comments.
Click here to Login
Head and Neck